Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells
Authors
Keywords
-
Journal
Nanoscale
Volume 9, Issue 29, Pages 10327-10334
Publisher
Royal Society of Chemistry (RSC)
Online
2017-06-22
DOI
10.1039/c7nr03042h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A protein corona-enabled blood test for early cancer detection
- (2017) D. Caputo et al. Nanoscale
- Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona
- (2017) Giulio Caracciolo et al. TRENDS IN BIOTECHNOLOGY
- Personalized protein corona on nanoparticles and its clinical implications
- (2017) Claudia Corbo et al. Biomaterials Science
- Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties
- (2016) Arafeh Bigdeli et al. ACS Nano
- The protein corona of circulating PEGylated liposomes
- (2016) Sara Palchetti et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Protein corona: The golden gate to clinical applications of nanoparticles
- (2016) Morteza Mahmoudi INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Effects of the protein corona on liposome–liposome and liposome–cell interactions
- (2016) Ennio Tasciotti et al. International Journal of Nanomedicine
- Mapping of Molecular Structure of the Nanoscale Surface in Bionanoparticles
- (2016) Luciana M. Herda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Emerging understanding of the protein corona at the nano-bio interfaces
- (2016) Morteza Mahmoudi et al. Nano Today
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
- (2016) Claudia Corbo et al. Nanomedicine
- Constructing bifunctional nanoparticles for dual targeting: improved grafting and surface recognition assessment of multiple ligand nanoparticles
- (2016) Maria Cristina Lo Giudice et al. Nanoscale
- Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
- (2016) Marilena Hadjidemetriou et al. Nanoscale
- Nanoparticles-cell association predicted by protein corona fingerprints
- (2016) S. Palchetti et al. Nanoscale
- In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry
- (2016) Maria Cristina Lo Giudice et al. Nature Communications
- Exploitation of nanoparticle–protein corona for emerging therapeutic and diagnostic applications
- (2016) S. Palchetti et al. Journal of Materials Chemistry B
- In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
- (2015) Marilena Hadjidemetriou et al. ACS Nano
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- The nanoparticle biomolecule corona: lessons learned – challenge accepted?
- (2015) D. Docter et al. CHEMICAL SOCIETY REVIEWS
- Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
- (2015) Giulio Caracciolo et al. LANGMUIR
- Crucial role of the protein corona for the specific targeting of nanoparticles
- (2015) Morteza Mahmoudi et al. Nanomedicine
- Liposome–protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines
- (2015) Giulio Caracciolo Nanomedicine-Nanotechnology Biology and Medicine
- Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide
- (2015) Mohammad Javad Hajipour et al. Nanoscale
- Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties
- (2015) Rong Liu et al. Nanoscale
- Mapping protein binding sites on the biomolecular corona of nanoparticles
- (2015) Philip M. Kelly et al. Nature Nanotechnology
- Lipid composition: a “key factor” for the rational manipulation of the liposome–protein corona by liposome design
- (2015) G. Caracciolo et al. RSC Advances
- Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface
- (2015) Delyan R. Hristov et al. Scientific Reports
- Personalized protein coronas: a “key” factor at the nanobiointerface
- (2014) Mohammad J. Hajipour et al. Biomaterials Science
- Selective Targeting Capability Acquired with a Protein Corona Adsorbed on the Surface of 1,2-Dioleoyl-3-trimethylammonium Propane/DNA Nanoparticles
- (2013) Giulio Caracciolo et al. ACS Applied Materials & Interfaces
- Mechanism of Polyplex- and Lipoplex-Mediated Delivery of Nucleic Acids: Real-Time Visualization of Transient Membrane Destabilization without Endosomal Lysis
- (2013) Zia ur Rehman et al. ACS Nano
- Temperature: The “Ignored” Factor at the NanoBio Interface
- (2013) Morteza Mahmoudi et al. ACS Nano
- Potential New Mechanisms of Placental Damage in Celiac Disease: Anti-Transglutaminase Antibodies Impair Human Endometrial Angiogenesis1
- (2013) Nicoletta Di Simone et al. BIOLOGY OF REPRODUCTION
- Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery
- (2013) Ana Lilia Barrán-Berdón et al. LANGMUIR
- Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells
- (2013) Daniela Pozzi et al. Nanoscale
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
- (2013) Stefan Tenzer et al. Nature Nanotechnology
- Liposome-like nanostructures for drug delivery
- (2013) Weiwei Gao et al. Journal of Materials Chemistry B
- Protein corona formation around nanoparticles – from the past to the future
- (2013) Pablo del Pino et al. Materials Horizons
- Questioning the use of PEGylation for drug delivery
- (2013) Johan J. F. Verhoef et al. Drug Delivery and Translational Research
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Cationic liposome/DNA complexes: from structure to interactions with cellular membranes
- (2012) Giulio Caracciolo et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Biomolecular coronas provide the biological identity of nanosized materials
- (2012) Marco P. Monopoli et al. Nature Nanotechnology
- Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment
- (2011) Carl D. Walkey et al. CHEMICAL SOCIETY REVIEWS
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
- (2011) Marco P. Monopoli et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Evolution of the Protein Corona of Lipid Gene Vectors as a Function of Plasma Concentration
- (2011) Giulio Caracciolo et al. LANGMUIR
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- AJCC Cancer Staging Manual
- (2010) James R. Egner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol–DOPE/DNA lipoplexes in serum
- (2009) Giulio Caracciolo et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Structural Stability and Increase in Size Rationalize the Efficiency of Lipoplexes in Serum
- (2009) Cristina Marchini et al. LANGMUIR
- Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
- (2007) Marie Gaumet et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now